ARS Pharmaceuticals, Inc. — Director's Dealing 2020

Dec 8, 2020

SEC Form 3/A — Form 3/A

Issuer: Silverback Therapeutics, Inc. (SBTX)
CIK: 0001671858
Period of Report: 2020-12-03

Reporting Person: Odegard Valerie (President and CSO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$1.08	2028-12-17	Common Stock (34691)		Direct

Footnotes

F1: 25% of the Shares vested on January 18, 2019 and the remaining shares shall vest in 36 equal monthly installments thereafter.

F2: These shares were omitted from the reporting person's original Form 3.